Seerpharma.com.au :: Pharmaceutical Consulting & Training :: Validation, GMP & Compliance UK | Singapore | Korea

   

 

 

Dyslipidemia: Diagnosis

Description: Dyslipidemia is a disorder of the amount of lipids in the blood, and is a primary risk factor for the development of atherosclerosis and subsequent cardiovascular diseases. Therefore, understanding and treating dyslipidemia is a key step in preventing life-threatening events such as stroke and myocardial infarction. This course will acquaint you with the current guidelines and strategies for diagnosing dyslipidemia.

COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

DIAGNOSIS
4. Objectives
5. Strategies for Screening Dyslipidemia
6. Follow-up to Screening
7. NCEP Guidelines
8. ESCP2 Guidelines
9. Clinical Evaluation
10. Progress Check

CONCLUSION
11. Summary


COURSE OBJECTIVES
Students completing this course should be able to:
  • Understand how dyslipidemia is diagnosed
  • Understand how dyslipidemia is managed
  • Understand the methods used to calculate risk for cardiovascular disease
  • List the three main tools used in a complete clinical evaluation
  • Describe the roles of patient history and laboratory tests in screening patients for dyslipidemias

 

   

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.

© SeerPharma Pty Ltd 2008 | Resources | Privacy Policy